Fabricated Sterility Tests Earn Brassica Pharma a Warning Letter after Failed Inspection
Brassica Pharma, a maker of sterile semi-solids, received an FDA Warning Letter for failure to test every batch for sterility as well as fabrication of test results for batches not tested, among other violations.
Source: Drug Industry Daily